Cargando…
Incidence and Risk Factors for 30-Day Readmission after Inpatient Chemotherapy among Acute Lymphoblastic Leukemia Patients
Chemotherapy for acute lymphoblastic leukemia (ALL) patients is complex and intense, resulting in a high readmission rate. We aimed to identify the incidence, causes, and risk factors of readmission following inpatient chemotherapy among ALL patients, using 2016 National Readmission Database. We app...
Autores principales: | Tran, Phuong T., Slayton, William B., Dalal, Mansi, Brown, Joshua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720128/ https://www.ncbi.nlm.nih.gov/pubmed/33066571 http://dx.doi.org/10.3390/healthcare8040401 |
Ejemplares similares
-
Disease Severity and Risk Factors of 30-Day Hospital Readmission in Pediatric Hospitalizations for Pneumonia
por: Lewis, Motomori O., et al.
Publicado: (2022) -
An inpatient multidisciplinary educational approach to reduce 30-day heart failure readmissions
por: Aljabri, Ahmed
Publicado: (2021) -
Inpatient Readmissions and Emergency Department Visits within 30 Days of a Hospital Admission
por: Brennan, Jesse J., et al.
Publicado: (2015) -
Risk factors for 30-day readmission following hypoglycemia-related emergency room and inpatient admissions
por: Emons, M F, et al.
Publicado: (2016) -
Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
por: Yang, Sara, et al.
Publicado: (2022)